Loading clinical trials...
Loading clinical trials...
A Study of Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS Study).
Conditions
Interventions
Hymecromone
Locations
2
United States
Stanford Clinic
Redwood City, California, United States
Stanford Clinic
Stanford, California, United States
Start Date
May 10, 2023
Primary Completion Date
May 1, 2027
Completion Date
December 1, 2027
Last Updated
June 13, 2025
NCT04753996
NCT05750498
NCT02137668
NCT05896137
NCT05740358
NCT04133792
Lead Sponsor
Aparna Goel
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions